Clinical Trial Update: A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR-1819 for moderate-to-severe atopic dermatitis; actively recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SHR-1819

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Moderate-to-severe Atopic Dermatitis | Phase 2 | Status: RECRUITING